Exact Mass: 440.1558

Exact Mass Matches: 440.1558

Found 166 metabolites which its exact mass value is equals to given mass value 440.1558, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Candesartan

2-ethoxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid

C24H20N6O3 (440.1597)


Candesartan is an angiotensin-receptor blocker (ARB) that may be used alone or with other agents to treat hypertension. It is administered orally as the prodrug, candesartan cilexetil, which is rapidly converted to its active metabolite, candesartan, during absorption in the gastrointestinal tract. Candesartan lowers blood pressure by antagonizing the renin-angiotensin-aldosterone system (RAAS); it competes with angiotensin II for binding to the type-1 angiotensin II receptor (AT1) subtype and prevents the blood pressure increasing effects of angiotensin II. Unlike angiotensin-converting enzyme (ACE) inhibitors, ARBs do not have the adverse effect of dry cough. Candesartan may be used to treat hypertension, isolated systolic hypertension, left ventricular hypertrophy and diabetic nephropathy. It may also be used as an alternative agent for the treatment of heart failure, systolic dysfunction, myocardial infarction and coronary artery disease. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 79 CONFIDENCE standard compound; EAWAG_UCHEM_ID 2804 CONFIDENCE standard compound; INTERNAL_ID 2137 CONFIDENCE standard compound; INTERNAL_ID 8182 Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3]. Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3].

   

Marchantin A

Marchantin A

C28H24O5 (440.1624)


   

Aminopterin

2-[(4-{[(4-amino-2-imino-2,3-dihydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioate

C19H20N8O5 (440.1557)


Aminopterin Syndrome Sine Aminopterin (ASSA, OMIM 600325) is an embryopathy caused by maternal treatment with the olic acid antagonist aminopterin has been recognized since 1952 when aminopterin was used as an abortifacient. The characteristic phenotype of the children who survived infancy after having been exposed to aminopterin or its methyl derivative, methotrexate, in early pregnancy included a very unusual facies, skull anomalies, and skeletal defects.(OMIM). Aminopterin is an antimetabolite drug used in treatment of cancer and autoimmune diseases. It acts by inhibiting the metabolism of folic acid. - Wikipedia. The effects of the drug on intracellular metabolic processes, due to the inhibitory action on the enzyme dihydrofolate reductase, show that the result of this inhibition is more complex and is not limited to blockade of the reduction of folic acid alone. Although rescue methods are important in prevention of lethal effects of methotrexate, some metabolic pathways are insufficiently rescued, resulting in toxic reactions following methotrexate administration.(PMID 6398629). Aminopterin Syndrome Sine Aminopterin (ASSA, OMIM 600325) is an embryopathy caused by maternal treatment with the olic acid antagonist aminopterin has been recognized since 1952 when aminopterin was used as an abortifacient. The characteristic phenotype of the children who survived infancy after having been exposed to aminopterin or its methyl derivative, methotrexate, in early pregnancy included a very unusual facies, skull anomalies, and skeletal defects.(OMIM);

   

Propylene glycol alginate

3-({3,4-dihydroxy-6-[(2-hydroxypropoxy)carbonyl]-5-methyloxan-2-yl}oxy)-4,5-dihydroxy-6-methoxyoxane-2-carboxylic acid

C17H28O13 (440.153)


Propylene glycol alginate is a stabiliser, emulsifier, thickener, formulation aid, surface active agent and flavouring adjunct or adjuvant for foodstuffs Propylene glycol alginate (PGA) is an emulsifier, stabilizer, and thickener used in food products. It is a food additive with E number E405. Chemically, propylene glycol alginate is an ester of alginic acid, which is derived from kelp. Some of the carboxyl groups are esterified with propylene glycol, some are neutralized with an appropriate alkali, and some remain free. Stabiliser, emulsifier, thickener, formulation aid, surface active agent and flavouring adjunct or adjuvant for foodstuffs

   

Azobilirubin

4-(2-{5-[(3-ethenyl-4-methyl-5-oxo-2,5-dihydro-1H-pyrrol-2-ylidene)methyl]-4-methyl-3-propyl-1H-pyrrol-2-yl}diazen-1-yl)benzene-1-sulfonic acid

C22H24N4O4S (440.1518)


   

Butyrolactone derivative

Methyl 4-hydroxy-2-[(3-hydroxy-2,2-dimethyl-3,4-dihydro-2H-1-benzopyran-6-yl)methyl]-3-(4-hydroxyphenyl)-5-oxo-2,5-dihydrofuran-2-carboxylic acid

C24H24O8 (440.1471)


   

2,2-Dimethylpropanoyloxymethyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3R)-5-oxopyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate

2,2-Dimethylpropanoyloxymethyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3R)-5-oxopyrrolidin-3-yl]sulphanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C20H28N2O7S (440.1617)


   

Metreton

[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl] dihydrogen phosphate

C21H29O8P (440.16)


   

Auranticin A

Auranticin A

C24H24O8 (440.1471)


   

butyrolactone IV

(+)-Butyrolactone IV

C24H24O8 (440.1471)


   
   

Neomarchantin B

Neomarchantin B

C28H24O5 (440.1624)


   

(+)-12a-Hydroxyerythynone

(+)-12a-Hydroxyerythynone

C24H24O8 (440.1471)


   

9,11-Dihydroxy-2,3,6-trimethoxy-8-prenhyl-6a,12a-didehydrorotenone

9,11-Dihydroxy-2,3,6-trimethoxy-8-prenhyl-6a,12a-didehydrorotenone

C24H24O8 (440.1471)


   

marchantin H

marchantin H

C28H24O5 (440.1624)


   

7,8-Dehydroperrottetin F

7,8-Dehydroperrottetin F

C28H24O5 (440.1624)


   

Kopsinitarine D

Kopsinitarine D

C23H24N2O7 (440.1583)


   
   

3,5,8-Trimethoxy-3,4-methylenedioxy-7-prenyloxyflavone

2- (1,3-Benzodioxol-5-yl) -3,5,8-trimethoxy-7- [ (3-methyl-2-butenyl) oxy ] -4H-1-benzopyran-4-one

C24H24O8 (440.1471)


   

N-(tert-Butyl)-2-[2-(2,4-dichlorophenoxy)acetyl]decahydroisoquinoline-3-carboxamide

N-(tert-Butyl)-2-[2-(2,4-dichlorophenoxy)acetyl]decahydroisoquinoline-3-carboxamide

C22H30Cl2N2O3 (440.1633)


   

Butyrolactone III

Butyrolactone III

C24H24O8 (440.1471)


   

(8Z)-2,15-dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-3(30),4,6,8,10(29),11,13,16(21),17,19,25,27-dodecaene-4,5,17-triol 1

(8Z)-2,15-dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-3(30),4,6,8,10(29),11,13,16(21),17,19,25,27-dodecaene-4,5,17-triol 1

C28H24O5 (440.1624)


   

(20S)-14-oxapentacyclo[20.2.2.210,13.115,19.02,7]nonacosa-1(24),2(7),3,5,10(29),11,13(28),15,17,19(27),22,25-dodecaene-5,16,20,24-tetrol

(20S)-14-oxapentacyclo[20.2.2.210,13.115,19.02,7]nonacosa-1(24),2(7),3,5,10(29),11,13(28),15,17,19(27),22,25-dodecaene-5,16,20,24-tetrol

C28H24O5 (440.1624)


CONFIDENCE Predicted

   

(E)-2-phenylmethylene-3-methoxy-4-[(2,3-diphenylpropionic acid methyl ester)-3-yl]-5-oxo-2(2H)-furylidene|isoravenelone methyl ester

(E)-2-phenylmethylene-3-methoxy-4-[(2,3-diphenylpropionic acid methyl ester)-3-yl]-5-oxo-2(2H)-furylidene|isoravenelone methyl ester

C28H24O5 (440.1624)


   

2-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-biopterin|2-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)biopterin|limipterin

2-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-biopterin|2-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)biopterin|limipterin

C17H24N6O8 (440.1656)


   

butyrolactone V

butyrolactone V

C24H24O8 (440.1471)


   

NCGC00183926-01

NCGC00183926-01

C24H24O8 (440.1471)


   

10-O-(Z)-cinnamoyl-2-oxo-6-deoxyneoanisatin

10-O-(Z)-cinnamoyl-2-oxo-6-deoxyneoanisatin

C24H24O8 (440.1471)


   

3,5,8-Tri-Me,3,4-methylene ether,7-O-(3-methyl-2-butenyl)-Gossypetin

3,5,8-Tri-Me,3,4-methylene ether,7-O-(3-methyl-2-butenyl)-Gossypetin

C24H24O8 (440.1471)


   
   

3,4-DihydrothonningineC

3,4-DihydrothonningineC

C24H24O8 (440.1471)


   
   

(2E)-3,4-dimethoxycinnamyl 3-(3,4-diacetoxyphenyl)acrylate

(2E)-3,4-dimethoxycinnamyl 3-(3,4-diacetoxyphenyl)acrylate

C24H24O8 (440.1471)


   

19,20-alpha-epoxy-12,15-dihydroxy-11-methoxyicajine

19,20-alpha-epoxy-12,15-dihydroxy-11-methoxyicajine

C23H24N2O7 (440.1583)


   

uvaridacol B

uvaridacol B

C24H24O8 (440.1471)


   

2-O-acetyl-6-O-methylzeylenol

2-O-acetyl-6-O-methylzeylenol

C24H24O8 (440.1471)


   

5,7,5-trimethoxy-6-(3-hydroxy-3-methyl-trans-but-1-enyl)-3,4-methylenedioxy flavone

5,7,5-trimethoxy-6-(3-hydroxy-3-methyl-trans-but-1-enyl)-3,4-methylenedioxy flavone

C24H24O8 (440.1471)


   

Cortisonsulfat-Pyridiniumsalz

Cortisonsulfat-Pyridiniumsalz

C21H28O8S (440.1505)


   
   
   

1,6-di-O-cinnamoyl-beta-D-glucopyranoside

1,6-di-O-cinnamoyl-beta-D-glucopyranoside

C24H24O8 (440.1471)


   

O4-[O4,O6-((Xi)-1-Carboxy-aethyliden)-beta-D-galactopyranosyl]-3,6-anhydro-L-galactose-dimethylacetal|O4-[O4,O6-((Xi)-1-carboxy-ethylidene)-beta-D-galactopyranosyl]-3,6-anhydro-L-galactose-dimethylacetal

O4-[O4,O6-((Xi)-1-Carboxy-aethyliden)-beta-D-galactopyranosyl]-3,6-anhydro-L-galactose-dimethylacetal|O4-[O4,O6-((Xi)-1-carboxy-ethylidene)-beta-D-galactopyranosyl]-3,6-anhydro-L-galactose-dimethylacetal

C17H28O13 (440.153)


   

JGB1741

JGB1741

C27H24N2O2S (440.1558)


JGB1741 (ILS-JGB-1741) is a potent and specific SIRT1 activity inhibitor with an IC50 of ~15 μM. JGB1741 is a weak SIRT2 and SIRT3 inhibitor with an all IC50>100 μM. JGB1741 increases the acetylated p53 levels leading to p53-mediated apoptosis with modulation of Bax/Bcl2 ratio, cytochrome c release and PARP cleavage. JGB1741 has the potential for breast cancer research[1].

   

candesartan

candesartan

C24H20N6O3 (440.1597)


C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2137 Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3]. Candesartan (CV 11974) is an orally active angiotensin II AT1-Receptor blocker and PPAR-γ agonist. Candesartan has potent and long-lasting antihypertensive effects. Candesartan can be used for the research of hypertension, chronic heart failure (CHF) and Traumatic brain injury (TBI)[1][2][3].

   

Candesartan (Atacand)

Candesartan (Atacand)

C24H20N6O3 (440.1597)


   

(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid

NCGC00380585-01!(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid

C24H24O8 (440.1471)


   

methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

NCGC00179715-03!methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

Aminopterin

2-[[4-[(2,4-diaminopteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid

C19H20N8O5 (440.1557)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor D004791 - Enzyme Inhibitors > D005493 - Folic Acid Antagonists

   

methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

7,8,19,20-Tetrahydro-15,18-etheno-2,6:9,13-dimetheno-1,14-benzodioxacyclodocosin-11,12,24-triol

(8Z)-2,15-dioxapentacyclo[22.2.2.13,7.110,14.016,21]triaconta-3(30),4,6,8,10(29),11,13,16(21),17,19,25,27-dodecaene-4,5,17-triol 1

C28H24O5 (440.1624)


CONFIDENCE Predicted

   

(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid [IIN-based on: CCMSLIB00000845225]

NCGC00380585-01!(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid [IIN-based on: CCMSLIB00000845225]

C24H24O8 (440.1471)


   

(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid [IIN-based: Match]

NCGC00380585-01!(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid [IIN-based: Match]

C24H24O8 (440.1471)


   

methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate [IIN-based on: CCMSLIB00000846943]

NCGC00179715-03!methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate [IIN-based on: CCMSLIB00000846943]

C24H24O8 (440.1471)


   

methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate [IIN-based: Match]

NCGC00179715-03!methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate [IIN-based: Match]

C24H24O8 (440.1471)


   

methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate [IIN-based on: CCMSLIB00000846940]

NCGC00179715-03!methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate [IIN-based on: CCMSLIB00000846940]

C24H24O8 (440.1471)


   

(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid [IIN-based on: CCMSLIB00000845223]

NCGC00380585-01!(E)-3-[1-[(E)-but-2-en-2-yl]-9-hydroxy-10-(hydroxymethyl)-3-methoxy-4-methyl-6-oxobenzo[b][1,4]benzodioxepin-7-yl]but-2-enoic acid [IIN-based on: CCMSLIB00000845223]

C24H24O8 (440.1471)


   

methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate_major

methyl 2-[[3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl]methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate_major

C24H24O8 (440.1471)


   

auranticin A_major

auranticin A_major

C24H24O8 (440.1471)


   

Asp Gly Ser Tyr

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C18H24N4O9 (440.1543)


   

Asp Gly Tyr Ser

(3S)-3-amino-3-[({[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C18H24N4O9 (440.1543)


   

Asp Ser Gly Tyr

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}methyl)carbamoyl]-2-hydroxyethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Asp Ser Tyr Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Asp Tyr Gly Ser

(3S)-3-amino-3-{[(1S)-1-[({[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Asp Tyr Ser Gly

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-hydroxyethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Gly Asp Ser Tyr

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Gly Asp Tyr Ser

(3S)-3-(2-aminoacetamido)-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Gly Ser Asp Tyr

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Gly Ser Tyr Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]butanedioic acid

C18H24N4O9 (440.1543)


   

Gly Tyr Asp Ser

(3S)-3-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Gly Tyr Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]butanedioic acid

C18H24N4O9 (440.1543)


   

Ser Asp Gly Tyr

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-[({[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C18H24N4O9 (440.1543)


   

Ser Asp Tyr Gly

(3S)-3-[(2S)-2-amino-3-hydroxypropanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Ser Gly Asp Tyr

(3S)-3-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Ser Gly Tyr Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]butanedioic acid

C18H24N4O9 (440.1543)


   

Ser Tyr Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C18H24N4O9 (440.1543)


   

Ser Tyr Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}butanedioic acid

C18H24N4O9 (440.1543)


   

Tyr Asp Gly Ser

(3S)-3-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-[({[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]propanoic acid

C18H24N4O9 (440.1543)


   

Tyr Asp Ser Gly

(3S)-3-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-{[(1S)-1-[(carboxymethyl)carbamoyl]-2-hydroxyethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Tyr Gly Asp Ser

(3S)-3-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C18H24N4O9 (440.1543)


   

Tyr Gly Ser Asp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-hydroxypropanamido]butanedioic acid

C18H24N4O9 (440.1543)


   

Tyr Ser Asp Gly

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C18H24N4O9 (440.1543)


   

Tyr Ser Gly Asp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxypropanamido]acetamido}butanedioic acid

C18H24N4O9 (440.1543)


   

Dricoid

3-({3,4-dihydroxy-6-[(2-hydroxypropoxy)carbonyl]-5-methyloxan-2-yl}oxy)-4,5-dihydroxy-6-methoxyoxane-2-carboxylic acid

C17H28O13 (440.153)


   

(4-CHLOROBENZYL)TRIPHEYLPHOSPHONIUM TETRAFLUOROBORATE

(4-CHLOROBENZYL)TRIPHEYLPHOSPHONIUM TETRAFLUOROBORATE

C25H22BF4P (440.1488)


   

2-[[4-[(2-cyanoethyl)(2-phenoxyethyl)amino]phenyl]azo]-5-nitrobenzonitrile

2-[[4-[(2-cyanoethyl)(2-phenoxyethyl)amino]phenyl]azo]-5-nitrobenzonitrile

C24H20N6O3 (440.1597)


   

4-[[4-(aminocarbonyl)phenyl]azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide

4-[[4-(aminocarbonyl)phenyl]azo]-3-hydroxy-N-(2-methoxyphenyl)naphthalene-2-carboxamide

C25H20N4O4 (440.1484)


   

2-((4-METHOXYPHENYL)AMINO)-1-(2-(TRIFLUOROMETHYL)BENZYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE

2-((4-METHOXYPHENYL)AMINO)-1-(2-(TRIFLUOROMETHYL)BENZYL)-1H-BENZO[D]IMIDAZOLE-5-CARBOXAMIDE

C23H19F3N4O2 (440.146)


   

1,4-bis(4-phenylphenyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-3,6-dione

1,4-bis(4-phenylphenyl)-2,5-dihydropyrrolo[3,4-c]pyrrole-3,6-dione

C30H20N2O2 (440.1525)


   

3-hydroxy-4-[(2-methyl-5-nitrophenyl)azo]-N-(o-tolyl)naphthalene-2-carboxamide

3-hydroxy-4-[(2-methyl-5-nitrophenyl)azo]-N-(o-tolyl)naphthalene-2-carboxamide

C25H20N4O4 (440.1484)


   

3,4,5-TRIBENZYLOXYBENZOIC ACID

3,4,5-TRIBENZYLOXYBENZOIC ACID

C28H24O5 (440.1624)


   
   

1-METHYL-3-TRIFLUOROMETHYL-5-TRIBUTYLSTANNYLPYRAZOLE

1-METHYL-3-TRIFLUOROMETHYL-5-TRIBUTYLSTANNYLPYRAZOLE

C17H31F3N2Sn (440.1461)


   
   
   

(4Z)-4-[(5-carbamoyl-2-methoxyphenyl)hydrazinylidene]-3-oxo-N-phenylnaphthalene-2-carboxamide

(4Z)-4-[(5-carbamoyl-2-methoxyphenyl)hydrazinylidene]-3-oxo-N-phenylnaphthalene-2-carboxamide

C25H20N4O4 (440.1484)


   

(4Z)-4-[[2-methoxy-5-(phenylcarbamoyl)phenyl]hydrazinylidene]-3-oxonaphthalene-2-carboxamide

(4Z)-4-[[2-methoxy-5-(phenylcarbamoyl)phenyl]hydrazinylidene]-3-oxonaphthalene-2-carboxamide

C25H20N4O4 (440.1484)


   

Prednisolone phosphate

Prednisolone phosphate

C21H29O8P (440.16)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

   

Ozanimod Hydrochloride

Ozanimod Hydrochloride

C23H25ClN4O3 (440.1615)


D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents > D000081243 - Sphingosine 1 Phosphate Receptor Modulators C308 - Immunotherapeutic Agent

   

(4r)-N-[4-({[2-(Dimethylamino)ethyl]amino}carbonyl)-1,3-Thiazol-2-Yl]-4-Methyl-1-Oxo-2,3,4,9-Tetrahydro-1h-Beta-Carboline-6-Carboxamide

(4r)-N-[4-({[2-(Dimethylamino)ethyl]amino}carbonyl)-1,3-Thiazol-2-Yl]-4-Methyl-1-Oxo-2,3,4,9-Tetrahydro-1h-Beta-Carboline-6-Carboxamide

C21H24N6O3S (440.1631)


   

2,2-Dimethylpropanoyloxymethyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3R)-5-oxopyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate

2,2-Dimethylpropanoyloxymethyl (4R,5S,6S)-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-3-[(3R)-5-oxopyrrolidin-3-yl]sulphanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid

C20H28N2O7S (440.1617)


   

Maruchantin E

Maruchantin E

C28H24O5 (440.1624)


   

N,N-diacetyl-thiochitobiose

N,N-diacetyl-thiochitobiose

C16H28N2O10S (440.1465)


   

4-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-3-propyl-1H-pyrrol-2-yl]diazenyl]benzenesulfonic acid

4-[[5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-3-propyl-1H-pyrrol-2-yl]diazenyl]benzenesulfonic acid

C22H24N4O4S (440.1518)


   

Cortisol phosphate(2-)

Cortisol phosphate(2-)

C21H29O8P-2 (440.16)


   

N-(2,4-dinitrophenyl)glycyl-L-lysyl-beta-alanine

N-(2,4-dinitrophenyl)glycyl-L-lysyl-beta-alanine

C17H24N6O8 (440.1656)


   

(2R,3R,4S,5R)-2-acetamido-4-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5,6-trihydroxyhexanoic acid

(2R,3R,4S,5R)-2-acetamido-4-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5,6-trihydroxyhexanoic acid

C16H28N2O12 (440.1642)


   

Aminofolic acid

Aminofolic acid

C19H20N8O5 (440.1557)


   

12a-Hydroxyerythynone

12a-Hydroxyerythynone

C24H24O8 (440.1471)


   

Hydroxyerythynone

Hydroxyerythynone

C24H24O8 (440.1471)


   
   

JP1302 dihydrochloride

JP1302 dihydrochloride

C24H26Cl2N4 (440.1534)


JP1302 dihydrochloride is a potent, selective, high affinity antagonist of the α2C-adrenoceptor, with a Kb of 16 nM and a Ki of 28 nM for the human α2C-receptor. JP1302 dihydrochloride shows antidepressant and antipsychotic-like effects. JP1302 dihydrochloride can be used for neuropsychiatric disorders and renal dysfunction research[1][2][3].

   

methyl (1r,2r,4r,5r,7r,11s,12s,15s,23r)-4,11-dihydroxy-18-methoxy-3-oxo-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17,19,21-triene-16-carboxylate

methyl (1r,2r,4r,5r,7r,11s,12s,15s,23r)-4,11-dihydroxy-18-methoxy-3-oxo-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17,19,21-triene-16-carboxylate

C23H24N2O7 (440.1583)


   

methyl (1r,2r,4s,5r,7r,11s,12s,15s,23r)-4,11-dihydroxy-18-methoxy-3-oxo-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17,19,21-triene-16-carboxylate

methyl (1r,2r,4s,5r,7r,11s,12s,15s,23r)-4,11-dihydroxy-18-methoxy-3-oxo-6-oxa-8,16-diazaoctacyclo[10.10.1.0¹,¹⁵.0²,⁷.0⁴,¹⁵.0⁵,¹².0⁸,²³.0¹⁷,²²]tricosa-17,19,21-triene-16-carboxylate

C23H24N2O7 (440.1583)


   

methyl (2r)-2-[(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-4-hydroxyphenyl)methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

methyl (2r)-2-[(3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-4-hydroxyphenyl)methyl]-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

(e,2z,4e)-n-[(1z)-3-[(4s,5r,6s,8r,9z,11e)-5,17-dihydroxy-2-oxo-3,7-dioxatricyclo[11.4.0.0⁶,⁸]heptadeca-1(17),9,11,13,15-pentaen-4-yl]prop-1-en-1-yl]-4-(methoxyimino)but-2-enimidic acid

(e,2z,4e)-n-[(1z)-3-[(4s,5r,6s,8r,9z,11e)-5,17-dihydroxy-2-oxo-3,7-dioxatricyclo[11.4.0.0⁶,⁸]heptadeca-1(17),9,11,13,15-pentaen-4-yl]prop-1-en-1-yl]-4-(methoxyimino)but-2-enimidic acid

C23H24N2O7 (440.1583)


   

2,15-dioxapentacyclo[22.2.2.1³,⁷.1¹⁰,¹⁴.0¹⁶,²¹]triaconta-1(26),3,5,7(30),10(29),11,13,16,18,20,24,27-dodecaene-4,5,17-triol

2,15-dioxapentacyclo[22.2.2.1³,⁷.1¹⁰,¹⁴.0¹⁶,²¹]triaconta-1(26),3,5,7(30),10(29),11,13,16,18,20,24,27-dodecaene-4,5,17-triol

C28H24O5 (440.1624)


   

methyl (2r)-4-hydroxy-3-(4-hydroxyphenyl)-2-{[(2r)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]methyl}-5-oxofuran-2-carboxylate

methyl (2r)-4-hydroxy-3-(4-hydroxyphenyl)-2-{[(2r)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]methyl}-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

n-(3-{5,17-dihydroxy-2-oxo-3,7-dioxatricyclo[11.4.0.0⁶,⁸]heptadeca-1(17),9,11,13,15-pentaen-4-yl}prop-2-en-1-yl)-4-(methoxyimino)but-2-enimidic acid

n-(3-{5,17-dihydroxy-2-oxo-3,7-dioxatricyclo[11.4.0.0⁶,⁸]heptadeca-1(17),9,11,13,15-pentaen-4-yl}prop-2-en-1-yl)-4-(methoxyimino)but-2-enimidic acid

C23H24N2O7 (440.1583)


   

5-[(1e)-2-(3-hydroxyphenyl)ethenyl]-3-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}benzene-1,2-diol

5-[(1e)-2-(3-hydroxyphenyl)ethenyl]-3-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}benzene-1,2-diol

C28H24O5 (440.1624)


   

(1r,2s,4r,6r)-14-hydroxy-10-methoxy-4,12-dimethyl-6-{[(2s)-5-oxooxolan-2-yl]methyl}-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

(1r,2s,4r,6r)-14-hydroxy-10-methoxy-4,12-dimethyl-6-{[(2s)-5-oxooxolan-2-yl]methyl}-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

C24H24O8 (440.1471)


   

methyl (2r)-4-hydroxy-3-(4-hydroxyphenyl)-2-{[(2r)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-6-yl]methyl}-5-oxofuran-2-carboxylate

methyl (2r)-4-hydroxy-3-(4-hydroxyphenyl)-2-{[(2r)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-6-yl]methyl}-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

methyl (2s,3r)-3-[(5z)-4-methoxy-2-oxo-5-(phenylmethylidene)furan-3-yl]-2,3-diphenylpropanoate

methyl (2s,3r)-3-[(5z)-4-methoxy-2-oxo-5-(phenylmethylidene)furan-3-yl]-2,3-diphenylpropanoate

C28H24O5 (440.1624)


   

methyl (2s,3r)-3-[(5e)-4-methoxy-2-oxo-5-(phenylmethylidene)furan-3-yl]-2,3-diphenylpropanoate

methyl (2s,3r)-3-[(5e)-4-methoxy-2-oxo-5-(phenylmethylidene)furan-3-yl]-2,3-diphenylpropanoate

C28H24O5 (440.1624)


   

(1ar,1br,3r,3ar,5s,7br,9r,9ar)-5-[(1s)-1-bromo-2-hydroxyethyl]-3-hydroxy-1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-9-yl acetate

(1ar,1br,3r,3ar,5s,7br,9r,9ar)-5-[(1s)-1-bromo-2-hydroxyethyl]-3-hydroxy-1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-9-yl acetate

C22H33BrO4 (440.1562)


   

2,16-dioxapentacyclo[23.2.2.1³,⁷.0¹⁰,¹⁵.0¹⁷,²²]triaconta-1(27),3,5,7(30),10,12,14,17,19,21,25,28-dodecaene-4,5,18-triol

2,16-dioxapentacyclo[23.2.2.1³,⁷.0¹⁰,¹⁵.0¹⁷,²²]triaconta-1(27),3,5,7(30),10,12,14,17,19,21,25,28-dodecaene-4,5,18-triol

C28H24O5 (440.1624)


   

2-(2h-1,3-benzodioxol-5-yl)-3,5,8-trimethoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one

2-(2h-1,3-benzodioxol-5-yl)-3,5,8-trimethoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one

C24H24O8 (440.1471)


   

3,8,15,20-tetraoxatricyclo[20.2.2.2¹⁰,¹³]octacosa-1(24),10,12,22,25,27-hexaene-2,9,14,21-tetrone

3,8,15,20-tetraoxatricyclo[20.2.2.2¹⁰,¹³]octacosa-1(24),10,12,22,25,27-hexaene-2,9,14,21-tetrone

C24H24O8 (440.1471)


   

methyl 3-[4-methoxy-2-oxo-5-(phenylmethylidene)furan-3-yl]-2,3-diphenylpropanoate

methyl 3-[4-methoxy-2-oxo-5-(phenylmethylidene)furan-3-yl]-2,3-diphenylpropanoate

C28H24O5 (440.1624)


   

methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-{[2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-6-yl]methyl}-5-oxofuran-2-carboxylate

methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-{[2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-6-yl]methyl}-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

(3ar,4s,9as)-4-[4-(acetyloxy)-3-methoxyphenyl]-7-methoxy-1-oxo-3h,3ah,4h,9h,9ah-naphtho[2,3-c]furan-6-yl acetate

(3ar,4s,9as)-4-[4-(acetyloxy)-3-methoxyphenyl]-7-methoxy-1-oxo-3h,3ah,4h,9h,9ah-naphtho[2,3-c]furan-6-yl acetate

C24H24O8 (440.1471)


   

3-hydroxy-5-{[(4r,5r,6e,8e,11s)-3,5,14,16-tetrahydroxy-4-methyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8,12(16),13-hexaen-11-yl]amino}benzoic acid

3-hydroxy-5-{[(4r,5r,6e,8e,11s)-3,5,14,16-tetrahydroxy-4-methyl-2-azabicyclo[10.3.1]hexadeca-1(15),2,6,8,12(16),13-hexaen-11-yl]amino}benzoic acid

C23H24N2O7 (440.1583)


   

(1r,4s,5r,6s)-6-(acetyloxy)-5-[(benzoyloxy)methyl]-5-hydroxy-4-methoxycyclohex-2-en-1-yl benzoate

(1r,4s,5r,6s)-6-(acetyloxy)-5-[(benzoyloxy)methyl]-5-hydroxy-4-methoxycyclohex-2-en-1-yl benzoate

C24H24O8 (440.1471)


   

(2e)-3-{4-[(2e)-but-2-en-2-yl]-14-hydroxy-15-(hydroxymethyl)-6-methoxy-7-methyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-12-yl}but-2-enoic acid

(2e)-3-{4-[(2e)-but-2-en-2-yl]-14-hydroxy-15-(hydroxymethyl)-6-methoxy-7-methyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-12-yl}but-2-enoic acid

C24H24O8 (440.1471)


   

methyl (2r)-4-hydroxy-3-(4-hydroxyphenyl)-2-{[(2s)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]methyl}-5-oxofuran-2-carboxylate

methyl (2r)-4-hydroxy-3-(4-hydroxyphenyl)-2-{[(2s)-2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]methyl}-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

n-(4,5-dihydroxy-2-{[1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)oxan-3-yl)ethanimidic acid

n-(4,5-dihydroxy-2-{[1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)oxan-3-yl)ethanimidic acid

C17H24N6O8 (440.1656)


   

14-hydroxy-10-methoxy-4,12-dimethyl-6-[(5-oxooxolan-2-yl)methyl]-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

14-hydroxy-10-methoxy-4,12-dimethyl-6-[(5-oxooxolan-2-yl)methyl]-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

C24H24O8 (440.1471)


   

2,15-dioxapentacyclo[20.2.2.2¹⁶,¹⁹.1³,⁷.1¹⁰,¹⁴]triaconta-1(24),3(30),4,6,10(29),11,13,16(28),17,19(27),22,25-dodecaene-4,17,18-triol

2,15-dioxapentacyclo[20.2.2.2¹⁶,¹⁹.1³,⁷.1¹⁰,¹⁴]triaconta-1(24),3(30),4,6,10(29),11,13,16(28),17,19(27),22,25-dodecaene-4,17,18-triol

C28H24O5 (440.1624)


   

(1s,6r,8r,12s,13s,23s)-16,23-dihydroxy-17-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-11(25),15,17,19-tetraene-21,24-dione

(1s,6r,8r,12s,13s,23s)-16,23-dihydroxy-17-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-11(25),15,17,19-tetraene-21,24-dione

C23H24N2O7 (440.1583)


   

(1ar,1br,3r,3ar,5s,7br,9r,9ar)-5-[(1r)-1-bromo-2-hydroxyethyl]-3-hydroxy-1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-9-yl acetate

(1ar,1br,3r,3ar,5s,7br,9r,9ar)-5-[(1r)-1-bromo-2-hydroxyethyl]-3-hydroxy-1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-9-yl acetate

C22H33BrO4 (440.1562)


   

n-[(2r,3r,4r,5s,6r)-4,5-dihydroxy-2-{[(1s,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

n-[(2r,3r,4r,5s,6r)-4,5-dihydroxy-2-{[(1s,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C17H24N6O8 (440.1656)


   

n-[(2r,3r,4r,5s,6r)-4,5-dihydroxy-2-{[(1r,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

n-[(2r,3r,4r,5s,6r)-4,5-dihydroxy-2-{[(1r,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid

C17H24N6O8 (440.1656)


   

6-(3-hydroxy-3-methylbut-1-en-1-yl)-5,7-dimethoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

6-(3-hydroxy-3-methylbut-1-en-1-yl)-5,7-dimethoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

C24H24O8 (440.1471)


   

n-(4,5-dihydroxy-2-{[(1r,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)oxan-3-yl)ethanimidic acid

n-(4,5-dihydroxy-2-{[(1r,2s)-1-hydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)propan-2-yl]oxy}-6-(hydroxymethyl)oxan-3-yl)ethanimidic acid

C17H24N6O8 (440.1656)


   

5-(1-bromo-2-hydroxyethyl)-3-hydroxy-1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-9-yl acetate

5-(1-bromo-2-hydroxyethyl)-3-hydroxy-1a,5,7b-trimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9h,9ah-cyclopropa[a]phenanthren-9-yl acetate

C22H33BrO4 (440.1562)


   

methyl (2r)-4-hydroxy-2-{[(3r)-3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]methyl}-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

methyl (2r)-4-hydroxy-2-{[(3r)-3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]methyl}-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

{3,4,5-trihydroxy-6-[(3-phenylprop-2-enoyl)oxy]oxan-2-yl}methyl 3-phenylprop-2-enoate

{3,4,5-trihydroxy-6-[(3-phenylprop-2-enoyl)oxy]oxan-2-yl}methyl 3-phenylprop-2-enoate

C24H24O8 (440.1471)


   

(1r,2s,4r,6r)-14-hydroxy-10-methoxy-4,12-dimethyl-6-{[(2r)-5-oxooxolan-2-yl]methyl}-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

(1r,2s,4r,6r)-14-hydroxy-10-methoxy-4,12-dimethyl-6-{[(2r)-5-oxooxolan-2-yl]methyl}-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

C24H24O8 (440.1471)


   

methyl (2r)-4-hydroxy-2-({4-hydroxy-3-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]phenyl}methyl)-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

methyl (2r)-4-hydroxy-2-({4-hydroxy-3-[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]phenyl}methyl)-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

(2z,4z)-n-[(2e)-3-[(4s,5r,6s,8r,9z,11e)-5,17-dihydroxy-2-oxo-3,7-dioxatricyclo[11.4.0.0⁶,⁸]heptadeca-1(17),9,11,13,15-pentaen-4-yl]prop-2-en-1-yl]-4-(methoxyimino)but-2-enimidic acid

(2z,4z)-n-[(2e)-3-[(4s,5r,6s,8r,9z,11e)-5,17-dihydroxy-2-oxo-3,7-dioxatricyclo[11.4.0.0⁶,⁸]heptadeca-1(17),9,11,13,15-pentaen-4-yl]prop-2-en-1-yl]-4-(methoxyimino)but-2-enimidic acid

C23H24N2O7 (440.1583)


   

methyl (2r)-4-hydroxy-2-{[(3s)-3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]methyl}-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

methyl (2r)-4-hydroxy-2-{[(3s)-3-hydroxy-2,2-dimethyl-3,4-dihydro-1-benzopyran-6-yl]methyl}-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

6-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-5,7-dimethoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

6-[(1e)-3-hydroxy-3-methylbut-1-en-1-yl]-5,7-dimethoxy-2-(7-methoxy-2h-1,3-benzodioxol-5-yl)chromen-4-one

C24H24O8 (440.1471)


   

4-[4-(acetyloxy)-3-methoxyphenyl]-7-methoxy-1-oxo-3h,3ah,4h,9h,9ah-naphtho[2,3-c]furan-6-yl acetate

4-[4-(acetyloxy)-3-methoxyphenyl]-7-methoxy-1-oxo-3h,3ah,4h,9h,9ah-naphtho[2,3-c]furan-6-yl acetate

C24H24O8 (440.1471)


   

(6r)-9,11-dihydroxy-2,3,6-trimethoxy-8-(3-methylbut-2-en-1-yl)-6h-5,7-dioxatetraphen-12-one

(6r)-9,11-dihydroxy-2,3,6-trimethoxy-8-(3-methylbut-2-en-1-yl)-6h-5,7-dioxatetraphen-12-one

C24H24O8 (440.1471)


   

(1s,2r,4r,6s)-14-hydroxy-10-methoxy-4,12-dimethyl-6-{[(2s)-5-oxooxolan-2-yl]methyl}-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

(1s,2r,4r,6s)-14-hydroxy-10-methoxy-4,12-dimethyl-6-{[(2s)-5-oxooxolan-2-yl]methyl}-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

C24H24O8 (440.1471)


   

n-(3-{5,17-dihydroxy-2-oxo-3,7-dioxatricyclo[11.4.0.0⁶,⁸]heptadeca-1(17),9,11,13,15-pentaen-4-yl}prop-1-en-1-yl)-4-(methoxyimino)but-2-enimidic acid

n-(3-{5,17-dihydroxy-2-oxo-3,7-dioxatricyclo[11.4.0.0⁶,⁸]heptadeca-1(17),9,11,13,15-pentaen-4-yl}prop-1-en-1-yl)-4-(methoxyimino)but-2-enimidic acid

C23H24N2O7 (440.1583)


   

methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-{[2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]methyl}-5-oxofuran-2-carboxylate

methyl 4-hydroxy-3-(4-hydroxyphenyl)-2-{[2-(2-hydroxypropan-2-yl)-2,3-dihydro-1-benzofuran-5-yl]methyl}-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

2,15-dioxapentacyclo[22.2.2.1³,⁷.1¹⁰,¹⁴.0¹⁶,²¹]triaconta-1(26),3(30),4,6,10(29),11,13,16,18,20,24,27-dodecaene-4,17,18-triol

2,15-dioxapentacyclo[22.2.2.1³,⁷.1¹⁰,¹⁴.0¹⁶,²¹]triaconta-1(26),3(30),4,6,10(29),11,13,16,18,20,24,27-dodecaene-4,17,18-triol

C28H24O5 (440.1624)


   

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(2e)-3-phenylprop-2-enoyl]oxy}oxan-2-yl]methyl (2e)-3-phenylprop-2-enoate

[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[(2e)-3-phenylprop-2-enoyl]oxy}oxan-2-yl]methyl (2e)-3-phenylprop-2-enoate

C24H24O8 (440.1471)


   

(2e)-3-(3,4-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-[3,4-bis(acetyloxy)phenyl]prop-2-enoate

(2e)-3-(3,4-dimethoxyphenyl)prop-2-en-1-yl (2e)-3-[3,4-bis(acetyloxy)phenyl]prop-2-enoate

C24H24O8 (440.1471)


   

methyl 2-({3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl}methyl)-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

methyl 2-({3-[(3,3-dimethyloxiran-2-yl)methyl]-4-hydroxyphenyl}methyl)-4-hydroxy-3-(4-hydroxyphenyl)-5-oxofuran-2-carboxylate

C24H24O8 (440.1471)


   

(1s,2r,4r,6s)-14-hydroxy-10-methoxy-4,12-dimethyl-6-{[(2r)-5-oxooxolan-2-yl]methyl}-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

(1s,2r,4r,6s)-14-hydroxy-10-methoxy-4,12-dimethyl-6-{[(2r)-5-oxooxolan-2-yl]methyl}-5,7,17-trioxapentacyclo[9.6.2.0²,⁶.0⁸,¹⁸.0¹⁵,¹⁹]nonadeca-8(18),9,11,13,15(19)-pentaen-16-one

C24H24O8 (440.1471)


   

3-(3,4-dimethoxyphenyl)prop-2-en-1-yl 3-[3,4-bis(acetyloxy)phenyl]prop-2-enoate

3-(3,4-dimethoxyphenyl)prop-2-en-1-yl 3-[3,4-bis(acetyloxy)phenyl]prop-2-enoate

C24H24O8 (440.1471)


   

6-(acetyloxy)-5-[(benzoyloxy)methyl]-5-hydroxy-4-methoxycyclohex-2-en-1-yl benzoate

6-(acetyloxy)-5-[(benzoyloxy)methyl]-5-hydroxy-4-methoxycyclohex-2-en-1-yl benzoate

C24H24O8 (440.1471)